Abbott-Alere review in Brazil focuses on infectious disease in vitro diagnostics
Abbott Laboratories and Alere have filed paperwork for their proposed $5.8 billion deal with the Brazilian competition authority, citing overlaps in the market for infectious disease in vitro diagnostics (IVD) systems....To view the full article, register now.
Already a subscriber? Click here to view full article